SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
The Greater Cannabis Company, Inc. (GCAN) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 10/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
✗
HEALTH
0/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — GCAN
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.00
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.00
Book Value / Share$0.00
Revenue / Share$0.00
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$0.00 |
$0.00 |
$-103K |
- |
| 2017 |
$-0.03 |
$209.00 |
$-793.57K |
-379697.1% |
| 2018 |
$-0.03 |
$95.38K |
$-839.07K |
-879.8% |
| 2019 |
$-0.06 |
$7.12K |
$-2.15M |
-30166.6% |
| 2020 |
$-0.02 |
$48.04K |
$-2.58M |
-5367.4% |
| 2021 |
$0.00 |
$12.63K |
$-509.81K |
-4036.5% |
| 2022 |
$0.00 |
$0.00 |
$-543.5K |
- |
| 2023 |
$0.00 |
$0.00 |
$-188.4K |
- |
| 2024 |
$0.00 |
$0.00 |
$-179.04K |
- |
| 2025 |
$0.00 |
$0.00 |
$-331.61K |
- |
